The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved AstraZeneca’s Symbicort (Budesonide/ ...

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing blockbuster. The US District Court for the Northern District of West Virginia ...

We may earn commission from links on this page, but we only recommend products we love. Promise. How many times have you watched the Katseye "Better in Denim" commercial? The limit does not exist and ...

Equity benchmarks extended their winning run for the eighth consecutive session on Friday, logging their longest gaining ...

The Space Force has been working closely with private investment firms to get a leg up on emerging technologies. The result is a “pool” of companies with products the service wants, a senior defense ...

WASHINGTON — A new collaboration between commercial space and defense firms Varda Space Industries, LeoLabs, and Anduril successfully demonstrated advanced hypersonic vehicle tracking, the companies ...

Oil Marketing companies have cut the prices of 19 kg Liquefied Petroleum Gas (LPG) cylinders by ₹51.50, starting Monday, September 1, while there has been no change in the prices of 14.2 kg domestic ...

As a former claims handler and fraud investigator, Jason Metz has worked on a multitude of complex and multifaceted claims. The insurance industry can be seemingly opaque, and Jason enjoys breaking ...

"You’re not going to tell me that’s not Sabrina Carpenter sitting on that couch getting seduced by that cookie?" the Tiktoker wrote Sabrina Carpenter/YouTube; Kevin Carter/Getty Images A TikToker ...

WASHINGTON — NASA expects to spend up to $1.5 billion to support at least two companies to demonstrate crew-tended space stations as part of the agency’s revised approach to transition from the ...

Nomura Holdings is creating a U.S. commercial real estate platform with several key hires from rival investment bank Barclays. Nomura tapped Larry Kravetz as head of U.S. commercial real estate and ...

AstraZeneca Pharma India Limited announced that it has received a Show Cause Notice from the National Pharmaceutical Pricing Authority (NPPA) on September 11, 2025, regarding alleged overcharging for ...